Navigation Links
Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
Date:9/4/2008

- Agreement will enable HGS to generate revenue from available

manufacturing capacity - - Revenue potential from manufacturing alliances, including the alliance with Hospira, could amount to $30-60 million over the next three to four

years -

ROCKVILLE, Md., Sept. 4 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has entered into an exclusive agreement with Hospira, Inc., for manufacturing process development and commercial supply of select Hospira biopharmaceutical products. Financial terms were not disclosed, and specific products were not identified.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"We look forward to using our company's world-class manufacturing facilities, quality systems and process development capabilities to help advance and supply biopharmaceutical products for Hospira. We are pleased to be chosen by a company of Hospira's stature for such an important role," said Curran Simpson, Senior Vice President of Operations, HGS. "The priority focus of HGS continues to be the commercialization of our lead products. Agreements such as the one announced today will produce near-term revenue from available manufacturing capacity. We see potential for $30-60 million in revenue from manufacturing alliances, including this alliance with Hospira, over the next three to four years."

Protein and antibody process development and manufacturing are core HGS competencies. The Company currently produces several protein and antibody drugs in two state-of-the-art cGMP-compliant process development and manu
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
2. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
3. UC Riverside researcher develops novel method to grow human embryonic stem cells
4. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
5. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
6. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
7. Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
8. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
9. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
10. New map IDs the core of the human brain
11. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wswire/ -- Myriant Technologies LLC ("Myriant"), a...r of renewable bio-chemicals, Uhde Corporation of...e GmbH, one of the world,s leading engineering con...or the engineering, procurement & construction...based on renewable feedstocks. The execution of t...
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009).... 5 ThermoGenesis Corp. ... products for processing and storing adult stem ce...of fiscal 2010. ,, For the quarter ended Septem...2 million, a 15 percent increase over revenues of ...Company said the key contributors to the growth in...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...ws Accurate Marketing Claims Designed with Input f...ation,s leading livestock,cloning companies announ...management system that will allow food companies t...food processing chain., The program was developed...e last year with all critical participants in the ...
...., Dec. 19 SleepQuest, the leader in,at-home diag...nounced the,launch of an improved version of its m...r to better support its community of,patients, fam... increasing demand for in-home sleep testing and s...ite to meet the needs of our,expanding patient pop...
..., Dec. 19 BioForm Medical,Inc. (Nasdaq: BFRM ) t...Officer, will present a company overview at the up...being held from January 7-10, 2008. BioForm,Medica...y 7th, 2008 at 8:30,a.m. PST (11:30 am EST) at the... live and archived copy of the webcast of BioForm ...
Other Biology Technology:Top U.S. Cloning Companies Announce New System to Track Cloned Livestock 2SleepQuest Launches Updated Web Site 2BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008 2
(Date:11/6/2009)...h of the publication of On the Origin of Species, ...S) is publishing open access two peer-reviewed art...ts into evolution. , The two articles are by Kevi..., and James T. Costa of Western Carolina Universit...in," appeared in the October issue of the AIBS jou...
(Date:11/6/2009)...ills, MI-based Law Enforcement Intelligent Devices...and patent-pending Biometric Access Control System...uman Services, National Institutes of Health (NIH)...pport the NIH,s entire police force that is respon... agency. The project is expected to be completed ...
(Date:11/5/2009)... (NABT) will recognize Leonard C. Yannielli, profe...mmunity College (NVCC) in Waterbury, Connecticut, ... NABT annual professional development conference t... , The Evolution Education Award is cosponsored ...(AIBS) and Biological Sciences Curriculum Study (B...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2New artificial enzyme safer for nature 10482 1New artificial enzyme safer for nature 10482 2Now hear this 10478 1Assessing Embryo Metabolism May Aid IVF Success 59948 1Assessing Embryo Metabolism May Aid IVF Success 59948 2
...f a space-age, low-gravity training machine used b...mpacts on muscles and joints by nearly half when s...ir body weight. , The new study has implications ...njuries and for ordinary people returning from kne...sor Rodger Kram of CU-Boulder,s integrative physio...
...resistance on the rise, tuberculosis is emerging a... , But now, innovative research at Weill Cornell ...culosis has an as yet unsuspected weakness -- one.... , "Using novel techniques, we have identified a...nse that M. tuberculosis mounts against the acid...
...ay have found a defense against the Black Plague, ...ation in the Middle Ages and which government agen... Professor Henry Daniell and his team have develop...ffective against the plague. Findings of his Natio...appear in the August edition of Infection and Imm...
Other Biology News:Low-gravity training machine reduces joint, muscle impacts, says CU-Boulder study 2Low-gravity training machine reduces joint, muscle impacts, says CU-Boulder study 3Potential new drug target to fight tuberculosis identified 2Potential new drug target to fight tuberculosis identified 3UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
RayBio Mouse AngiogenesisAntibody Array I & 1.1 Service from Raybiotech, Inc.
Goat Anti-Syne-1 (N-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: